🔬Deep Research
BRTX — BioRestorative Therapies Inc · catalysts, narrative & risks
BioRestorative Therapies Inc. (NASDAQ: BRTX) — Point-in-Time Profile
Current Snapshot (as of Oct 12–13, 2026)
BioRestorative Therapies, Inc. (Melville, NY; founded 1997; ~14 employees) is a late-stage clinical regenerative-medicine company building cell/tissue-based therapies from adult stem cells across three programs: a disc/spine program (lead candidate BRTX-100), a metabolic program (ThermoStem), and a commercial BioCosmeceutical platform [1] [14] [15].
AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →